Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Kaohsiung J Med Sci ; 40(7): 660-670, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38801488

ABSTRACT

Bladder cancer (BC) poses high morbidity and mortality, with urinary exosomal microRNA (miR)-21 showing potential value in its diagnosis and prognosis, and we probed its specific role. We prospectively selected 116 BC patients and 116 healthy volunteers as the BC and control groups, respectively. BC urinary exosomal miR-146a-5p, miR-93-5p, miR-663b, miR-21, and miR-4454 relative expression levels were assessed. The correlations between clinical indexes and urinary exosomal miR-21, prognostic value of miR-21, and diagnostic value of the five candidate miRNAs, urine cytology, and miRNA joint diagnostic panel for BC and urinary exosomal miR-21, miR-4454, and urine cytology for Ta-T1 and T2-T4 stage BC were analyzed. Urinary exosomal miR-146a-5p, miR-93-5p, miR-663b, miR-21, and miR-4454 were highly expressed in BC patients. miR-146a-5p, miR-93-5p, miR-663b, miR-21, miR-4454, miRNA combined diagnostic panel, and urine cytology had certain diagnostic value for BC, with miR-21, miR-4454, and miRNA co-diagnostic panel showing the highest diagnostic value. Collectively, urinary exosomal miR-21 was closely related to Tumor-Node-Metastasis staging and grading in BC patients. Urinary exosomal miR-21 had high diagnostic value for BC and Ta-T1 and T2-T4 stage BC, and had high predictive value for BC poor prognosis, providing an effective indicator for the occurrence, development, and prognostic assessment of BC.


Subject(s)
Exosomes , MicroRNAs , Urinary Bladder Neoplasms , Humans , MicroRNAs/urine , MicroRNAs/genetics , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder Neoplasms/urine , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/pathology , Female , Exosomes/genetics , Exosomes/metabolism , Male , Middle Aged , Prognosis , Aged , Biomarkers, Tumor/urine , Biomarkers, Tumor/genetics , Early Detection of Cancer , Gene Expression Regulation, Neoplastic , Case-Control Studies , Neoplasm Staging
2.
Ying Yong Sheng Tai Xue Bao ; 28(3): 829-837, 2017 Mar 18.
Article in Chinese | MEDLINE | ID: mdl-29741009

ABSTRACT

A series of typical abandoned croplands in the regions of Ruanliang and Yingliang in the Ordos Plateau, China, were selected, and dynamics of the surface litter, biological soil crust and soil bulk density, soil texture, and soil moisture in different soil layers were investigated. The results showed that in the abandoned cropland in Ruanliang, the clay particle content and surface litter of the surface soil layer (0-10 cm) increased during the restoration process, while that of soil bulk density substantially decreased and soil water content slightly increased in the surface soil. In the medium soil layer (10-30 cm), the clay particle content increased and the soil water content slightly decreased. In the deep soil layer (30-50 cm), there was a relatively large variation in the physical properties. In the abandoned cropland in Yingliang, the coverage of litter and the coverage and thickness of the biological soil crust increased during the abandonment process. The surface soil bulk density, soil clay particle content and soil water content remained constant in 0-10 cm soil layer, while the physical properties varied substantially in 10-40 cm soil layer. The shallow distribution of the soil water content caused by the accumulation of the litter and clay particles on the soil surface might be the key reason of the replacement of the semi-shrub Artemisia ordosica community with a perennial grass community over the last 20 years of the abandoned cropland in Ruanliang. The relatively high soil water content in the shallow layer and the development of the biological soil crust might explain why the abandoned cropland in Yingliang was not invaded by the semi-shrub A. ordosica during the restoration process.


Subject(s)
Crops, Agricultural , Soil , China , Ecosystem , Water
3.
Chin J Integr Med ; 23(10): 733-739, 2017 Oct.
Article in English | MEDLINE | ID: mdl-27796823

ABSTRACT

OBJECTIVE: To determine whether additional Chinese medicine (CM) could prolong survival and improve the quality of life (QOL) in patients with advanced non-small cell lung cancer (NSCLC) compared with Western medicine (WM) alone. METHODS: This was a multicenter, prospective cohort study. A total of 474 hospitalized patients with stage III-IV NSCLC were recruited and divided into 2 groups. Patients in the WM group received radiotherapy, chemotherapy, and optimal supportive therapy according to the National Comprehensive Cancer Network (NCCN) guidelines. In the integrative medicine (IM) group, individualized CM (Chinese patent medicines and injections) and WM were administered. The primary end point was overall survival, and the secondary end points were time to disease progression, adverse events, and QOL. Follow-up clinical examinations and chest radiography were performed every 2 months. RESULTS: The median survival was 16.60 months in the IM group and 13.13 months in the WM group (P<0.01). The incidences of loss of appetite, nausea, and vomiting in the IM group were significantly lower than those in the WM group (P<0.05). The QOL based on Functional Assessment of Cancer Therapy-Lung in the IM group was markedly higher than that in the WM group at the fourth course (P<0.05). CONCLUSIONS: Additional CM may prolong survival and improve the QOL patients with NSCLC. The adverse effects of radio- and chemotherapy may be attenuated as CM is used in combination with conventional treatments.


Subject(s)
Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/pathology , Drugs, Chinese Herbal/therapeutic use , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology , Drugs, Chinese Herbal/adverse effects , Humans , Integrative Medicine , Middle Aged , Multivariate Analysis , Neoplasm Staging , Proportional Hazards Models , Prospective Studies , Quality of Life , Survival Analysis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...